Astley, Susan M.
Harkness, Elaine F.
Sergeant, Jamie C.
Warwick, Jane
Stavrinos, Paula
Warren, Ruth
Wilson, Mary
Beetles, Ursula
Gadde, Soujanya
Lim, Yit
Jain, Anil
Bundred, Sara
Barr, Nicola
Reece, Valerie
Brentnall, Adam R.
Cuzick, Jack
Howell, Tony
Evans, D. Gareth
Funding for this research was provided by:
Programme Grants for Applied Research (RP-PG-0707-10031)
Prevent Breast Cancer (GA09-003 and GA13-006)
Article History
Received: 22 June 2017
Accepted: 5 January 2018
First Online: 5 February 2018
Ethics approval and consent to participate
: Ethics approval for the study was through the North Manchester Research Ethics Committee (09/H1008/81). Informed consent was obtained from all participants on entry to the PROCAS study.
: Not applicable.
: Software licences for Volpara, Quantra and Densitas were provided free of charge under a research agreement by Volpara Health Technologies (Wellington, New Zealand), Hologic Inc (Marlborough, MA, USA) and Densitas Inc (Halifax, NS, Canada) respectively. The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.